Research has shown that exercise has significant benefits for people with Parkinson’s. But experts warn that too many with ...

Background: Respiratory dysfunction is an important contributor to morbidity and mortality in advanced Parkinson's disease ...

This study emphasizes that movement disorders such as tremor, parkinsonism, and myoclonus are particularly salient features of the acute neurologic manifestations of WNV infection. These findings ...

Childhood cancer is rare. Most children with one or more of these symptoms don't have leukaemia. But it's important to get your GP to check any of the symptoms out. Many symptoms of ALL are vague and ...

Care homes that have specialist staff experienced with caring for people with Parkinson’s are ideal for someone with Parkinson’s as they have specific needs. A person with Parkinson’s does not have ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug development for Parkinson’s disease. GSK will pay $80 million ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA removed the clinical hold on Novavax's ...

Acute and chronic conditions typically differ in how they develop and how long they last. Broadly speaking, acute conditions occur suddenly, have immediate or rapidly developing symptoms, and are ...

Is there anything I can do to lower my risk of developing Parkinson’s disease? Parkinson’s disease affects over 8.5 million people globally and is rising at an alarming rate: By 2030 ...

Currently, there are no marketed DMTs for PD. Credit: Kateryna Kon via Shutterstock. While Parkinson’s disease (PD) has a large and highly generalised therapeutic ...

For the first time, the British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) have collaborated to develop ...